MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is ...

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...